Given the association of some DDR genes with worse prognosis, and DDR alterations being an early event in prostate cancer, future clinical trials for patients with DDRm and an earlier stage of disease are important to improve outcomes for these patients. The gene discussed is DDR1; the disease is prostate cancer.